Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Ecological Momentary Assessment–Based Self‑Management for Stroke Recovery

Official title: Combining Machine Learning and Ecological Momentary Assessment of Depression, Cognitive Function and Daily Activity Behavior to Support Self-Management for Post-stroke Patients: A Feasibility Study

Run by The Hong Kong Polytechnic University · NCT07691411 · Data updated 2026-11-12

A small feasibility test will see if a smartphone app that tracks moods and daily activities, then gives personalized tips, can help adults in Hong Kong who have had a stroke feel better and function better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong, Hong Kong)
StatusRecruiting
StartedJanuary 6, 2026
Main results expectedSeptember 30, 2026
Study endsNovember 30, 2026
Registry record updatedJuly 8, 2026
Trial IDNCT07691411 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older, in Hong Kong, with a confirmed stroke, Cantonese proficiency, HK-MoCA score 18 or higher, and a smartphone.

Probably not a fit

Participants with moderate to severe cognitive impairment, active major psychiatric disorders other than depression, terminal illness, or conditions limiting self-care may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study tests a smartphone-based program that uses real-time symptom tracking and machine learning to support self-management after stroke. Participants use RehabCare Companion to complete brief daily surveys for a week, receive tailored self-care suggestions, and complete mood, cognitive, and functioning assessments before and after the program. The study also collects participant feedback through a group interview to gauge practicality and acceptability. The aim is to determine whether the approach is workable for post-stroke survivors and whether it can improve mood, cognitive function, or daily activities. Hong Kong Chinese-speaking adults with sufficient cognitive ability and a compatible smartphone are enrolled, with assessments conducted around the intervention period.

Why it matters

Potential benefit: If successful, the program could help stroke survivors manage mood and cognitive symptoms, potentially improving daily functioning.

How similar studies have gone: Prior research shows promise for EMA-based tools in chronic disease self-management, but applicability to post-stroke self-management remains exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adults aged 18 years or older
* having a confirmed diagnosis of stroke
* having sufficient proficiency in Cantonese to understand and respond to the assessments and prompts
* having a Hong Kong version of the Montreal Cognitive Assessment (HK-MoCA) score of 18 or higher
* having a smartphone.

Exclusion Criteria:

* they have moderate to severe cognitive impairment (a HK-MoCA score of 17 or lower)
* they have active psychiatric disorders other than depression (e.g., schizophrenia, bipolar disorder)
* they have a terminal illness or prognosis that suggests a limited life expectancy
* they have conditions that compromise their self-care ability (i.e., bedbound).

Where it's running

  • Queen Elizabeth Hospital
    Hong Kong, Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.